Immunologic Response toHaemophilus influenzaeType b (Hib) Conjugate Vaccine and Risk Factors for Carriage among Hib Carriers and Noncarriers in Southwestern Alaska
- 1 June 2006
- journal article
- clinical trial
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 13 (6) , 620-626
- https://doi.org/10.1128/cvi.00077-06
Abstract
ContinuedHaemophilus influenzaetype b (Hib) carriage in rural Alaska contributes to the ongoing risk of invasive disease. Community-wide Hib carriage surveys were conducted in three villages in southwestern Alaska. Sixteen carriers and 32 age- and village-matched controls were enrolled and were vaccinated with Hib oligosaccharide-CRM197conjugate vaccine. Serum immunoglobulin G (IgG) concentration, antibody avidity, and serum bactericidal activity (SBA) were measured prior to Hib vaccination and 2 and 12 months after vaccination. We identified no demographic or behavioral factors associated with Hib colonization. Prior to vaccination, Hib carriers had a higher IgG geometric mean concentration than controls did (8.2 versus 1.6 μg/ml;P< 0.001) and a higher SBA geometric mean titer (7,132 versus 1,235;P= 0.006). Both groups responded to vaccination with increased IgG and SBA. These data illustrate the role of Hib colonization as an immunizing event and show that Hib carriers in communities with ongoing transmission have no evidence of reduced immune responsiveness that may have put them at risk for colonization.Keywords
This publication has 37 references indexed in Scilit:
- Predictors for Haemophilus influenzae Colonization, Antibiotic Resistance and for Sharing an Identical Isolate Among Children Attending 16 Licensed Day-Care Centers in MichiganThe Pediatric Infectious Disease Journal, 2006
- Avidity Determinations for Haemophilus influenzae Type b Anti-Polyribosylribitol Phosphate AntibodiesClinical and Vaccine Immunology, 2005
- Functional Antibody Activity Elicited by Fractional Doses ofHaemophilus influenzaeType b Conjugate Vaccine (Polyribosylribitol Phosphate–Tetanus Toxoid Conjugate)Clinical and Diagnostic Laboratory Immunology, 2001
- Measuring Socioeconomic Status/Position in Studies of Racial/Ethnic Disparities: Maternal and Infant HealthPublic Health Reports®, 2001
- Antibodies to Haemophilus influenzae Serotype b in The Netherlands a Few Years after the Introduction of Routine VaccinationClinical Infectious Diseases, 2001
- Prevention ofHaemophilus influenzaeType b Colonization by Vaccination: Correlation with Serum Anti‐Capsular IgG ConcentrationThe Journal of Infectious Diseases, 2000
- Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzas type b conjugate vaccinesThe Pediatric Infectious Disease Journal, 1995
- Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccinesThe Pediatric Infectious Disease Journal, 1993
- Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infantsThe Pediatric Infectious Disease Journal, 1993
- Systemic Haemophilus influenzae disease: An overviewThe Journal of Pediatrics, 1979